Journey to Wealth

Uzma Bhd - OUTPERFORM - 12 JUNE 2012

kiasutrader
Publish date: Wed, 13 Jun 2012, 03:15 PM

News    Yesterday, Uzma Bhd ('UZMA') announced that its wholly-owned subsidiary company, Uzma Engineering Sdn Bhd ("UESB") had been awarded a RM36.0m water injection studies contract from PETRONAS Carigali Sdn Bhd ("PCSB"). 

 The said contract is an Enhanced Oil Recovery (EOR) related project for a primary period of three(3) years (completion in May 2015) with an extension option of one (1) year (to end by May 2016) for the provision of integrated water injection studies.

Comments   We understand that this studies contract fetches relatively thin profit margin as this project is meant to provide a pilot project service to PETRONAS' entities with hope to entice more substantial contracts in the future just like the way UZMA initially launched its flagship product, UzmAPRES, earlier. 

 This is part of the replenishment contract for its orderbook, which stands at c.RM1.0b currently.

 For this water injection studies contract, the management did not reveal any further financial guidance as the EOR development is still in the preliminary stage.

 For illustration purpose, and based on assumption of a decent net margin of 5%, we are expecting a net profit contribution of RM0.35m for FY12E and RM1.80m and RM1.45m for FY13E and FY14E respectively. We have earlier imputed these into our estimates.

Outlook   We remain bullish on the company as Uzma has being actively engaged in EOR, which is the core focus of PETRONAS to boost the domestic Oil & Gas production.

Forecast   We are keeping our FY12-14E net earnings at RM22.3m-RM34.0m. 

Rating  MAINTAIN OUTPERFORM

Valuation    We are reaffirming our OUTPERFORM recommendation with target price unchanged at RM2.55, supported by 7.5x of FY13E EPS of 34.0 sen. 

Risks   Declining global crude oil price trend that will discourage O&G activities.  

Source: Kenanga
Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment